human serum, one of which was enriched with human lipoproteins. These serum pools were developed by the National Institute of Public Health and Environmental Hygiene (RIVM), Bilthoven, the Netherlands, to serve as calibrators for cholesterol assays.?
In vivo and in vitro findings suggest that this hypokalaemia is mediated by~2-adrenoceptor stimulation." Hence, it is relevant that non-selectivẽ -blockade (i.e.~, +~2) prevents the hypokalaemia of AMI 2 and that one of the hypokalaemic AMI patients reported by Rodger et al.' was taking rnetoprolol, a~,-selective blocker.
It would also be of interest to know if any of the AMI patients who did not develop hypokalaemia were on non-selective (i.e.~1~2)~-blockers. Like Mikhailidis and his colleagues, we are interested in the effects of~-blockers on plasma potassium in acute myocardial infarction, and we are grateful for the opportunity to reply to their letter. Five of our patients were on~-blockers and only one was hypokalaemic on admission. Of the four patients who were normokalacmic, two were on non-selective agen,ts and two were on cardioselective agents. Clearly, no conclusions can be drawn from this small study about the relative effects of the two classes of~ blockers. However. we have since examined plasma potassium levels on admission in a much larger number of patients. Our findings have yet to be submitted for publication, but we wish to report here that we have shown that~-blockers can maintain plasma potassium levels in acute myocardial infarction, and that non-selective agents are more effective than cardiosclective agents in this regard. J C RODGER, E SIMPSON Monklands District General Hospital, Airdrie, Lanarkshire M L6 OIS The use of heat-treated plasma for biochemical analysis We read the paper by Collinson, Stein and Light' on the effect of heat treatment of plasma with considerable interest but were surprised that their findings and conclusions differed from our previously reported
